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Abstract The presence of Ca2+-activated Cl− channels
(CaCCs) in vascular smooth muscle cells (SMCs) is well
established. Their molecular identity is, however, elusive.
Two distinct Ca2+-activated Cl− currents (ICl(Ca)) were
previously characterized in SMCs. We have shown that the
cGMP-dependent ICl(Ca) depends on bestrophin expression,
while the “classical” ICl(Ca) is not. Downregulation of
bestrophins did not affect arterial contraction but inhibited
the rhythmic contractions, vasomotion. In this study, we have
used in vivo siRNA transfection of rat mesenteric small
arteries to investigate the role of a putative CaCC,
TMEM16A. Isometric force, [Ca2+]i, and SMC membrane
potential were measured in isolated arterial segments. ICl(Ca)
and GTPγS-induced nonselective cation current were
measured in isolated SMCs. Downregulation of TMEM16A
resulted in inhibition of both the cGMP-dependent ICl(Ca) and
the “classical” ICl(Ca) in SMCs. TMEM16A downregulation
also reduced expression of bestrophins. TMEM16A
downregulation suppressed vasomotion both in vivo and
in vitro. Downregulation of TMEM16A reduced agonist
(noradrenaline and vasopressin) and K+-induced contractions.
In accordance with the depolarizing role of CaCCs,
TMEM16A downregulation suppressed agonist-induced
depolarization and elevation in [Ca2+]i. Surprisingly, K
+-
induced depolarization was unchanged but Ca2+ entry was
reduced. We suggested that this is due to reduced expression
of the L-type Ca2+ channels, as observed at the mRNA level.
Thus, the importance of TMEM16A for contraction is, at least
in part, independent from membrane potential. This study
demonstrates the significance of TMEM16A for two SMCs
ICl(Ca) and vascular function and suggests an interaction
between TMEM16A and L-type Ca2+ channels.
Keywords Ca2+-activated Cl− channel . Excitation–
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Introduction
Calcium-activated chloride channels (CaCCs) have been
intensely studied during the last decade [16]. This is, in part,
because these channels represent the largest remaining group of
membrane conductances for which the molecular identity is
uncertain [40]. Recent functional and structural studies
strengthen though the position of the TMEM16 family
(anoctamins), which are one of the most prominent candidates
for CaCCs [13, 15, 16, 20]. The heterologous overexpression of
at least somemembers of the TMEM16 family, i.e., TMEM16A
and TMEM16B, induces a ICl(Ca) with characteristics closely
resembling the properties of the endogenous ICl(Ca) in smooth
muscle cells (SMCs) [5, 43, 47]. Moreover, it has been shown
that native ICl(Ca) depends on TMEM16A expression [1, 8, 17,
24, 44]. Genetic knockout or ex vivo siRNA-based
downregulation of TMEM16A suppresses native ICl(Ca) and
abolishes some CaCC-dependent cellular functions [16, 20].
The presence of CaCCs in SMCs is well established [22, 23].
The SMC ICl(Ca) is well characterized and its functional
significance documented. Since Cl− is actively transported into
SMCs, increased SMC Cl− current depolarizes the cell
membrane [6] and ICl(Ca) has been suggested to participate in
excitation–contraction coupling. Agonist-induced Ca2+ release
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is generally thought to lead to CaCC-dependent membrane
depolarization which in turn opens voltage-gated Ca2+ channels,
which further increases the intracellular Ca2+. The native ICl(Ca)
has also been suggested to be important for SMC proliferation
during vascular remodeling and for mechanosensitive responses
of the arterial wall [46]. Recently, TMEM16A has been shown
to be important for ICl(Ca), for membrane potential, and for
myogenic tone in rat cerebral arteries [4].
We have previously shown that vascular SMC ICl(Ca) is
comprised of two currents [25]: in addition to the ICl(Ca) with
classical biophysical and pharmacological characteristics
[25, 27], we identified a cGMP-dependent ICl(Ca) in the same
SMCs. The two Cl− currents co-exist throughout the vascular
tree, although the relative expression differs between vascular
beds [26]. Interestingly, pulmonary arteries exhibit no cGMP-
dependent ICl(Ca) [25, 26]. Using siRNA, we have previously
demonstrated that knockdown of bestrophin expression is
associated with disappearance of the cGMP-dependent ICl(Ca)
in SMCs [27] but has no effect on the “classical” ICl(Ca).We also
found that knockdown of bestrophin is not important for
agonist-induced contraction [3]. This is consistent with other
studies showing that the Cl− gradient is not important for
agonist-induced vasoconstriction of rat mesenteric arteries [2].
A key role for ICl(Ca) in contraction is suggested in other species
and vascular beds, e.g., rabbit mesenteric arteries, although the
ion substitution experiments were not performed there [41].
Thus, the exact role of the “classical” ICl(Ca) for SMC agonist-
induced contraction remains unclear. However, downregulation
of bestrophins significantly suppresses vasomotion [3], which
supports the hypothesis that the cGMP-dependent ICl(Ca) is
important for synchronization of SMCs in the generation of
vasomotion [37].
In this study, we test the hypothesis that TMEM16A,
which is endogenously expressed in SMCs [8, 24, 44], is
necessary for the native ICl(Ca): to do so, we downregulated
TMEM16A in rat mesenteric small arteries in vivo with
siRNA [3, 27, 28]. We found that the presence of
TMEM16A is important for both the cGMP-independent
ICl(Ca) and the cGMP-dependent ICl(Ca). The interpretation
of this result is complicated, however, by our finding that
downregulation of TMEM16A leads to reduced expression
of bestrophins, which previously has been shown to be
important for the cGMP-dependent I Cl (Ca ) [27] .
Furthermore, downregulation of TMEM16A reduced the
contractile response and inhibited vasomotion. Elevations
in intracellular Ca2+ and membrane potential in response to
agonist stimulation were also reduced in TMEM16A-
downregulated arteries. However, the contractile response
to K+-induced depolarization was also reduced and this was
accompanied by a reduced expression of vascular voltage-
dependent L-type Ca2+ channels. The current study suggests
that TMEM16A is important for SMCs contraction in
membrane potential-dependent and potential-independent ways.
Methods
All experiments were approved by and conducted with
permission from the Animal Experiments Inspectorate of the
Danish Ministry of Justice.
In vivo siRNA transfection
A segment of rat mesenteric small arteries was transfected
in vivo as described previously [3, 28]. Shortly, Wistar male
rats were anesthetized with a subcutaneous injection of a
combination of Hypnorm (1 mg/100 g; VetaPharma Ltd.,
UK) and midazolam (0.5 mg/100 g; Hameln Pharm GMBH,
Germany). Supplementary anesthesia was given each half
hour during the transfection procedure. A medial laparotomy
was performed and a section of the mesentery was gently
pulled out. A short segment (~1 mm) of a first order branch
from the superior mesenteric artery was gently cleaned of fat
and the tip (~0.5 mm length) of an elastic micropipette
(MicroFill 34G-5; World Precision Instruments Inc., USA)
was inserted through a puncture made by a needle. The
downstream arteries were flushed with the transfection
solution and a clamp was placed near the entrance of the small
arteries to the gut wall to avoid backflow of blood from the
mesenteric arcade; care was taken to avoid overfilling of the
artery segments. Transfection was performed for 20 min;
every 2.5 min, the downstream clamp was released and the
arteries flushed with new transfection solution. After
transfection, the mesentery was returned to the peritoneal
cavity and the wound closed. The painkiller Temgesic®
(2 mL/100 g; Schering-Plough, Belgium) was given at the
end of the transfection.
TKO®-based transfection was used (Mirus Bio Co., USA).
The concentration of siRNA in the final transfection solution
was ~800 nM. The siRNA oligos were manufactured by
Eurofin MWG Operon (Germany) with TT overhang
(Table 1), and the efficiency of siRNA transfection was
initially tested on a smooth muscle cell line (A7r5) (not
shown). Two different siRNA directed against Tmem16a were
used in the study (Table 1): one was directed against exon 23
(Tmem16a -siRNA) and was used throughout the whole study,
while the second was directed against exon 22 (Tmem16a -
siRNA-2) and was used in some experiments. Two mesenteric
artery branches from one rat were transfected each time; one
with siRNA directed against Tmem16a and another with
control siRNA. Either nonrelated siRNA directed against
enhanced green fluorescent protein (eGFP; Ambion Ltd) or
nonfunctional siRNA directed against Tmem16a with four
mutated nucleotides was used as the control siRNA (Table 1).
Three days after transfection, rats were either used for
in vivo study or sacrificed by CO2 inhalation to permit
mesenteric arteries to be harvested for in vitro studies.
Arteries transfected with Tmem16a -siRNA, arteries
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transfected with control siRNA (either eGFP-siRNA or
mutated Tmem16a-siRNA), and nontransfected arteries from
the same rat were used for the following studies.
Contractile responses of mesenteric small arteries in vivo
Three days after transfection, rats were anesthetized using
ketamine (33 mg/100 g; Ketaminol®vet, Intervet International,
Holland) and xylazine (7.5 mg/100 g; Narcoxyl®vet, Intervet
International, Holland) administered subcutaneously and placed
in a chamber heated to 33–37 °C. A lateral laparotomy was
performed and a short segment (1.5–2 cm) of the intestine and
mesentery were carefully pulled out. A single branch of the
mesenteric artery was placed in a small reservoir (6.5 mm
width×6.5 mm length×3mm depth, corresponding to a volume





Primer (sequencing experiments) Sequence Target
rTM_47-66 F catcatgcaggacacacagg Bp 47–a
rTM_751-770 F tgcccacgaagaaggtgtac Bp 751–a
rTM_1555-1574 F ccttcatggagcactggaaa Bp 1555–a
rTM_1861-1880 F tgaactcctccccatctgtg Bp 1861–a
rTM_2540-2559 F agccatcagagccaaagaca Bp 2540–a
rTM_3361-3380 F aggccattatgcagggaagt Bp 3361–a
rTM_747-766R accttcttcgtgggcatctt Bp −766a
rTM_1054-1073R cgccgtttacttagaagggc Bp −1073a
rTM_1861-1880R cacagatggggaggagttca Bp −1880a
rTM_3090-3109R ctgtgggactgtggttgtta Bp −3109a
rTM_3694-3713R ccaggcttatttctgaccct Bp −3713a
rTM_4600-4619R gaacgctcagccacagactc Bp −4619a
siRNA Sequence
Tmem16a-siRNA (exon 23) cggucuucuuucuucuuucTT Ano1/NM_001107564.1b
mutated Tmem16a-siRNA cggucggcuuacaucuuucTT Ano1/NM_001107564.1b







α1a α-adrenergic receptors-F ccgttcttcctagtcatgcc Adra1a/NM_0171981.2b
α1a α-adrenergic receptors-R atgtctctgtgctgtccctc Adra1a/NM_017191.2b
α1b α-adrenergic receptors-F caagaactttcatgaggacaccc Adra1b/NM_016991.2b
α1b α-adrenergic receptors-R ccagaacaccaccttgaacac Adra1b/NM_016991.2b
α1d α-adrenergic receptors-F cggaccacagagtagcaagg Adra1d/NM_024483.1b
α1d α-adrenergic receptors-R tagcccagccagaagatgac Adra1d/NM_024483.1b
rBest1 (Applied Biosystems) Rn01451107_m1 Best1/NM_001011940.1b
rBest2 (Applied Biosystems) Rn00520372_m1 Best2/NM_001108895.1b
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the two sides of the reservoir. The openings between the
reservoir walls and the artery were sealed with high vacuum
grease (DowCorning GMBH,Wiesbaden, Germany). Thus, the
mesenteric artery segment in the reservoir was perfused but
isolated extraluminary from the rest of intestine and mesentery.
The reservoir was filled with physiological saline solution (PSS)
containing 10 mM HEPES (HEPES-PSS) bubbled with 5 %
CO2 in N2. During the experiment, the extracted intestine and
mesentery were kept moist using bandages soaked in HEPES-
PSS. Different noradrenaline (NA) concentrations were applied
by adding 10 μL corresponding stock solution prepared in
HEPES-PSS to the reservoir. Each concentration was applied
for 2–3 min.
The rat was placed on a microscope (Motic PSM-1000)
table and the artery was focused. Approximately 50 % of the
surrounding mesenteric fat was dissected from the top of the
segment to enable visualization of the inner diameter of the
artery. The arterial inner diameter was captured with a USB
CCD Monochrome Camera (DMK 41 AU02, Imaging
Source, Germany) attached to the microscope and processed
using DMT Vessel Acquisition Suite software (Danish Myo
Technology A/S, Denmark). The diameter measured
immediately after washout three times was not different from
the passive diameter measured in vivo in the presence of
10 μM papaverine hydrochloride, 1 μM phentolamine,
10 μM Y-27632, and 10 μM acetylcholine (data not shown).
Therefore, changes in vascular tone are expressed as a percent
reduction of the passive (washout) diameter.
mRNA quantification—quantitative polymerase chain
reaction (qPCR)
Arteries were dissected and stored in stabilizing reagent
RNAlater (Qiagen, VWR, Denmark). Isolated arterial
segments were homogenized in Tissue Lyser (0.033 Hz;
Qiagen, VWR, Denmark) for 3 min. RNA isolation was
carried out using RNeasy Micro kit (Qiagen, VWR,
Denmark) according to the manufacturer's protocol, followed
by standard reverse transcriptase. Quantitative PCR (qPCR)
was performed to assess the expression of specific RNAs
(Table 1) using Taqman probe technology (Tmem16a
mRNA quantification; Eurofins MWG Operon, Germany
and bestrophin mRNA quantification; Applied Biosystems,
Denmark) with the amplified sequence being different from
the siRNA-targeted sequence. Quantification of RNA forα1a,
α1b, and α1d adrenergic receptors was performed using a
SYBR Green assay. All amplifications were carried out on
MX3000P (Stratagene, USA). Gene expression was
normalized to GAPDH and transferrin receptor expression
(average Ct value) and presented as a ΔCt value.
Comparison of gene expression between nontransfected
control and transfected arteries was derived by subtracting
control ΔCt from the transfected ΔCt value, producing
ΔΔCt. Relative gene expression was calculated as
1/(2ΔΔCt), thereby standardizing the data to the nontransfected
control arteries from the same rat.
Analyses of Tmem16a splice variants
Primers used for amplification of different fragments of
Tmem16a are listed in Table 1. The PCR products obtained
from rat mesenteric artery and aorta cDNA were sequenced
(Eurofins MWG Operon, Germany) and aligned with the
predicted mRNA sequence using CLC bio-software (CLC
bio, Denmark).
Quantification of TMEM16A protein expression—single-cell
immunofluorescence
Single SMCs for single-cell immunofluorescence and
voltage-clamp studies were isolated from rat mesenteric small
arteries as described previously [25]. Briefly, artery segments
were dissected out, opened longitudinally, and placed in a
papain digestion solution at 4 °C overnight. The papain
digestion solution contained the following (in mM): NaCl
110, KCl 5, MgCl2 2, KH2PO4 0.5, NaH2PO4 0.5, NaHCO3
10, CaCl2 0.16, EDTA 0.49, Na-HEPES 10, glucose 10,
taurine 10, as well as 1.5 mg/mL papain, 1.6 mg/mL albumin,
and 0.4 mg/mL dl-dithiothreitol; pH was adjusted to 7.0.
Digestion was completed the next morning by heating the
sample to 37 °C for 2–5 min. Single cells were released by
trituration with a polyethylene pipette.
The single SMCs were fixated with 4 % formaldehyde
(in phosphate-buffered solution (PBS)) for 15 min. After
washing, unreacted fixative was quenched with 25 mM
glycine in PBS and cells were permeabilized with 0.1 %
Triton-X in PBS. Subsequently, the cells were incubated
with 0.1 % Triton-X in PBS solution containing the
primary antibody raised against TMEM16A (prediluted
ab53213 antibody, Abcam, UK) for 2 h at room
temperature. The cells were then washed and incubated
in the dark with Alexa Fluor 488-conjugated secondary
antibody for 45 min at room temperature (Invitrogen,
USA). After washing, the preparation was transferred to
the confocal microscope.
After excitation at 488 nm, the emission signal (LP
530 nm) was recorded and stored on the computer for later
analyses of fluorescence intensity using ImageJ (NIH, USA).
All recordings were made with the same microscope settings.
No staining was detected in preparations treated with only
secondary antibody without primary antibody (not shown).
The intensity of TMEM16A-downregulated SMCs was
normalized to the level in cells isolated from arteries
transfected with eGFP-siRNA.
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Voltage-clamp recordings of membrane currents
All experiments were made at room temperature (22–24 °C).
Patch pipettes were prepared from borosilicate glass
(PG15OT-7.5; Harvard Apparatus), pulled on a P-97 puller
(Sutter Instrument Co.) and fire-polished to achieve tip
resistances in the range of 5–10 MΩ. Recordings were made
with an Axopatch 200B amplifier (Axon Instruments, Inc.) in
whole-cell configuration as described previously [25, 27].
Data were sampled at a rate of 2 kHz and filtered at 1 kHz.
Data acquisition and analysis were done with the software
package Clampex 7 for Windows (Axon Instruments, Inc.).
Series resistance and capacitive current were routinely
compensated.
Ca2+-activated Cl− currents were measured at a holding
potential of −60mV. The Ca2+-activated currents were evoked
by patch pipette solution containing the following (in mM):
140 CsCl, 5.5 Ca(OH)2, 0.1MgATP, 6 EGTA, and 10HEPES,
at pH 7.35 (free calcium concentration 900 nM, estimated
using WEBMAXC v. 2.22 (Chris Patton, Stanford
University, USA)) [27]. The bath solution contained the
following (in mM): 140 CsCl, 0.1 CaCl2, and 10 HEPES, at
pH 7.4. In accordance with our previous findings [25, 26],
1 mM BaCl2 and 100 nM charybdotoxin were included in all
bath solutions to prevent the activation of outward current by
niflumic acid [14]. The current–voltage (I–V ) relationship
was determined by stepping the potentials (20mVincrements)
between −60 and +60 mV, maintaining the voltage at each
step for 1,500 ms. Sustained current amplitudes were
averaged for each step.
We compared the cGMP-dependent and the cGMP-
independent Ca2+-activated Cl− currents from the same cells
based on differences in their characteristics [25–27]: 100 μM
niflumic acid, 300 μM of the membrane-permeable cGMP
analog 8Br-cGMP, and 10 μM Zn2+ were used as indicated to
characterize the currents. We isolated the niflumic acid-
sensitive cGMP-independent Ca2+-activated Cl− current and
the cGMP-dependent Ca2+-activated Cl− current by
subtractions of the current after application of inhibitor
(niflumic acid and ZnCl2, respectively) from the current
before these agents were added [26]. Currents were normalized
to cell capacitances. The current slope conductances were
evaluated as the slope of the I–V relationship of corresponding
current.
Nonselective cationic current (INSC) was recorded as
described elsewhere [32]. SMCs were isolated by papain
digestion and bathed in the solution containing the following
(in mM): 126 NaCl, 6 KCl, 2 CaCl2, 1.2 MgCl2, 14 glucose,
and 10.5 HEPES, pH adjusted to 7.2 with NaOH. Before INSC
recording, this bath solution was replaced with a Cs+-rich
solution containing the following (in mM): 120 CsCl, 12
glucose, and 10 HEPES, pH adjusted to 7.2 with CsOH. The
pipette solution SMCs were dialyzed to evoke INSC current
which contained the following (in mM): 80 CsCl, 1 MgATP, 1
Na2GTP, 5 creatinine, 20 glucose, 10 HEPES, 10 BAPTA
(1,2-bis (2-aminophenoxy)-ethane-N ,N ,N ′,N ′-tetraacetic
acid), and 4.6 CaCl2 (free [Ca
2+]i estimated to 100 nM), pH
adjusted to 7.2 with CsOH.
Upon formation of a whole cell, the membrane voltage
was held at −50 mV and the changes in membrane current
were recorded. The current–voltage (I–V ) relationship was
determined by 200 ms voltage ramp from −90 to +90 mV.
The ramp was repeated every 10 s. INSC was evoked by
dialyzing SMCs with 400 μM GTPγS in the pipette
solution as described previously [32]. Omission of
GTPγS from the pipette solution (not shown) prevents
INSC development. At the end of the experiment, INSC
was inhibited by 10 μM GdCl3.
Isometric force
Transfected or nontreated second to third order segments of
the mesenteric artery were dissected out and cleaned of
connective tissue in ice-cold salt solution (PSS). The cleaned
arterial segments were mounted in an isometric wire
myograph (Danish Myo Technology A/S, Denmark) as
described previously [2, 3]. The myograph chamber was
heated to 37 °C, while the PSS was constantly aerated with
5 % CO2 in air. Force was recorded with a PowerLab 4/25 and
Chart7 data acquisition system (ADInstruments Ltd., New
Zealand) and converted to wall tension by dividing force with
double segment length. Concentration–response relationships
were constructed by cumulative NA (0.1–30 μM) or arginine
vasopressin (AVP, 0.15–15 nM) addition. Additionally, the
response to 10 mM caffeine and 124 mM K+ was tested.
Vasomotion was analyzed at the level of NA tone where the
amplitude was highest, i.e., approximately 50 % of maximal
tone [3] for both the in vitro and the in vivo experiments.
Vasomotion was analyzed in Chart7 (ADInstruments Ltd.,
New Zealand) by spectrum analysis.
Simultaneous measurements of isometric force
and intracellular calcium
Simultaneous measurements of isometric force and intracellular
Ca2+ were performed as described previously [28, 29]. Arteries
in the isometric myograph were loaded with 2.5 μM Fura-2
(Fura-2, AM; Invitrogen) in a loading buffer (final bath
concentration 0.04 % DMSO, 0.0016 % pluronic F127,
0.008 % Cremophor EL) for two consecutive 30-min periods
at 37 °C. Fura-2-loaded preparations were investigated on the
stage of an Olympus IX70 microscope equipped with an
Olympus LUCPlanFL N×20 objective (N.A. 0.45) and an
EasyRatioPro fluorescence imaging system (Photon
Technology International, NJ, USA). The arteries in the
isometric myograph were exited at 340 and 380 nm and
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emission was recorded at 510 nM. Concentration–response
relationships were constructed by cumulative NA
(0.1–30 μM) addition to the myograph bath. Responses to
10 mM caffeine and 60 mM K+ were tested. K+ response was
performed after pre-incubation with 1 μMphentolamine. At the
end of the experiment, the K+ response was recorded after
incubation with 10 μM nifedipine. Background fluorescence
(after quenching with 20 mM MnCl2) was determined at the
end of each experiment and subtracted. Intracellular Ca2+
([Ca2+]i) was expressed from 340/380 fluorescence ratio,
normalized to mean 340/380 fluorescence ratio in eGFP-
transfected arteries in the presence of 10 μM NA.
Membrane potential
The arterial segments were mounted as described above in the
isometric myograph. Intracellular recordings of membrane
potential were obtained using glass KCl-filled microelectrodes
with resistance in the range of 40–100 MΩ as previously
described [29]. A reference electrode (Ag–AgCl) was placed
in the myograph bath. Electrode resistance was routinely
compensated by balancing the Wheatstone bridge of the
amplifier (Intro-710, WPI) before impalements.
BODIPY-prazosin staining of α1-adrenergic receptors
in the arterial wall
Freshly dissected arteries were loaded for 90 min at room
temperature (in the dark) in PSS containing 100 nM
BODIPY®-FL-prazosin (B-7433, Life Technologies) in a
humidified chamber gassed with 5 % CO2 in air. After
loading, the arteries were washed with PSS and mounted on
slides for imaging with a LSM 5 Pascal confocal microscope
(Zeiss) using a×40 water immersion lens. BODIPY-prazosin
was excited by 488 nm argon laser and emitted light between
505 and 530 nm recorded. The pinhole, gain, and laser
excitation settings remained constant for all the experiments.
A Z-stack (1 μm image steps) was constructed in several
locations of the artery wall. A corresponding differential
interference contrast image was made for each section.
Data were analyzed by localizing the internal elastic lamina
(autofluorescence) in the Z-stack and analyzing the Z-image
4 μm above this (denoted SMC-IL). In a similar fashion, a Z-
stack image 4 μm under the adventitia border was analyzed
(denoted SMC-OL). The average area analyzed for each
image was 15,555 μm2. Each artery was analyzed in several
locations to provide a single average value for SMC-IL and
SMC-OL. Control experiments performed with pre-
incubation with 1 μM prazosin for 30 min prior to incubation
with 100 nM BODIPY-prazosin confirmed specificity of
binding to α1-adrenoceptors (data not shown).
Solutions and chemicals
The PBS for tissue isolation in immunohistochemical studies
contained the following (in mM): 137 NaCl, 2.7 KCl, 8.2
Na2HPO4, and 1.8 KH2PO4, at pH 7.4. The PSS for myograph
studies contained the following (in mM): 119 NaCl, 4.7 KCl,
1.18 KH2PO4, 1.17 MgSO4, 25 NaHCO3, 1.6 CaCl2, 0.026
EDTA, and 5.5 glucose, gassed with 5 % CO2 in air and
adjusted to pH 7.4. In solutions with increased K+
concentration, NaCl was substituted with equimolar KCl.
Complete Mini, EDTA-free protease inhibitor cocktail was
supplied from Roche Applied Science (Germany).
Charybdotoxin was purchased from Latoxan (France). All
other chemicals were purchased from Sigma Aldrich
(Denmark).
Data analysis
All data are presented as mean values±SEM. Differences
between means were tested by one-way ANOVA followed
by Bonferroni posttest or by t test where appropriate. P <0.05
was considered significant and n refers to the number of rats.
Results
Two splice variants of Tmem16a are expressed in rat
mesenteric small arteries and in aorta
Fragments of two splice variants of Tmem16a were amplified
from cDNA prepared from rat mesenteric artery RNA.
Subsequent sequencing confirmed these fragments to be a
part of Tmem16a gene product. Mesenteric small arteries
expressed “bc” (deletion of exon 15) or “cd” (deletion of exon
6b) splice variants in accordance with the nomenclature
suggested previously [11] (Fig. 1). The primers spanning
segment “a” did not amplify any PCR product.
Amplification and sequencing of cDNA from rat aorta
identified the same two splice variants (not shown).
In vivo transfection of rat mesenteric small arteries
with Tmem16a -siRNA downregulates the expression
of TMEM16A
Successful downregulation of Tmem16a 3 days after
transfection with Tmem16a -siRNA targeting exon 23 was
confirmed at the mRNA level. Tmem16a mRNA was
significantly reduced by Tmem16a -directed siRNA in
comparison with the controls: nontransfected arteries, arteries
transfected with mutated Tmem16a -siRNA, and arteries
transfected with eGFP-targeted siRNA (Fig. 2a). No
significant difference in Tmem16a expression was found
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between nontransfected control and arteries transfected either
with mutated siRNA or with eGFP-siRNA.
When Tmem16a -siRNA-2—which targets another exon
(exon 22)—was used for arterial transfection, Tmem16a
mRNA was also significantly reduced (24.9±5.3 % of the
level in nontransfected arteries; P =0.012, n =4) in
comparison with eGFP-target siRNA-transfected arteries
(117.0±18.6 %).
The effectiveness of transfection was also validated at the
protein level using immunoreactivity against TMEM16A in
freshly isolated SMCs (Fig. 2b, c). There was no significant
difference in TMEM16A protein expression between SMCs
isolated from arteries transfected with eGFP-targeted siRNA
and nontransfected arteries. Transfection with Tmem16a -
siRNA significantly reduced TMEM16A protein expression
in comparison with SMCs isolated from arteries transfected
with eGFP-targeted siRNA (Fig. 2b).
Downregulation of TMEM16A suppressed also mRNA
expression of bestrophin-1 (26.4±10.9 vs. 90.8±8.1 % in
eGFP-siRNA-transfected arteries, P =0.009, n =4),
bestrophin-2 (75.8±6.1 vs. 105.5±5.5 %, P =0.04, n =3), and
bestrophin-3 (14.7±5.5 vs. 101.8±15.5 %, P =0.002, n =5).
TMEM16A downregulation suppresses Ca2+-activated Cl−
currents in smooth muscle cells
In accordance with previous reports [25–27, 37], SMCs
freshly isolated from arteries transfected with nonrelated
siRNA expressed two Ca2+-activated Cl− conductances, the
“classical,” niflumic acid-sensitive ICl(Ca) and the cGMP-
dependent, Zn2+-sensitive ICl(Ca) (Fig. 3). SMCs dialyzedwith
intracellular solution containing 900 nM free Ca2+ had a
voltage- and time-dependent current which was significantly
suppressed by 100 μM niflumic acid (Fig. 3a, b). The
biophysical and pharmacological characteristics of this
niflumic acid-sensitive ICl(Ca) are indistinguishable from those
previously described for the “classical” ICl(Ca) [25–27]. The
addition of 8Br-cGMP, a membrane-permeable analog of
cGMP, in the presence of niflumic acid elicited a second
voltage- and time-independent current, which was inhibited
by 10 μM Zn2+ (Fig. 3a, b). This current corresponds to the
cGMP-dependent, Zn2+-sensitive I Cl(Ca) (Fig. 3c)
characterized previously [25–27].
SMCs isolated from the arteries transfected with nonrelated
siRNA had Ca2+-activated Cl− conductances similar to those
in nontransfected SMCs. There was no significant difference
in the niflumic acid-sensitive ICl(Ca) or the Zn
2+-sensitive
ICl(Ca) recorded from these two types of SMCs (data not
shown). Both of these ICl(Ca) were, however, significantly
diminished by TMEM16A downregulation (Fig. 3a–c). The
whole-cell slope conductances of the niflumic acid-sensitive
ICl(Ca) and the Zn
2+-sensitive ICl(Ca) were significantly
reduced in SMCs downregulated for TMEM16A in
comparison with the control (Fig. 3c).
TMEM16A downregulation suppresses NA-induced
contraction in vivo and inhibits diameter oscillations
There was no difference between diameters of fully relaxed
arteries (passive diameters) either transfected with eGFP-
targeted siRNA or downregulated for TMEM16A (Fig. 4a).
Nonstimulated arteries of both groups had similar basal tone
in vivo before NAwas applied (12±5 vs. 21±6 % for eGFP-
siRNA transfected and downregulated for TMEM16A
arteries, respectively; n =5). NA constricted eGFP-siRNA in
a concentration-dependent manner (−logEC50 was 6.32±0.16,
n =5; Fig. 4a, b). Arteries downregulated for TMEM16A have
small responses to NA (Fig. 4a, c).
All arteries transfected with siRNA-targeted eGFP (n =5)
produced rhythmic oscillations in the inner diameter when
stimulated with NA (Fig. 4b, d). Two out of seven arteries
downregulated for TMEM16A did not oscillate in diameter in
Segment ‘a’ Segment ‘c’ Segment ‘d’Segment ‘b’
a
21b 543 76 12111098 1413 19181716 2120 2322
b
5 76 12111098 1413
5 76 12111098 1413
19181716 2120 232221b 43








Fig. 1 Splice variants of Tmem16a expressed in rat mesenteric small
arteries. a Predicted exon structure of rat Tmem16a . Exons corresponding
to fragments “a,” “b,” “c,” and “d” [11, 12] are indicated. b Splice
variants found in rat mesenteric small arteries are presented. These splice
variants omit either exon 6b or exon 15 corresponding to “b” or “d”
fragments of the protein, respectively. Segment “a” was not detected and
all variants contained segment “c”
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the presence of NA. The remaining five TMEM16A-
downregulated arteries oscillated irregularly and with
significantly reduced amplitude (Fig. 4c, d).
TMEM16A contributes to the agonist-induced contraction
of isolated mesenteric small arteries in vitro
Passive inner diameters were not different between the groups
of isolated arteries in vitro (Table 2). When active wall tension
was compared, the arteries downregulated for TMEM16A had
reduced agonist-induced contraction in comparison with
nontransfected arteries and arteries transfected with
nonfunctional siRNA (Fig. 5). Thus, NA concentration–
response curves indicated a significantly reduced sensitivity
to the agonist and suppressed maximal contractile responses
in TMEM16A-downregulated isolated arteries (Fig. 5a, b;
Table 2). Surprisingly, arteries transfected with mutated,
nonfunctional siRNA were more sensitive to NA in
comparison with nontransfected arteries (Table 2). This was
not a consequence of the transfection procedure since the
contractile responses of eGFP-siRNA-transfected isolated
arteries were not different from the responses of
nontransfected isolated arteries (Fig. 5c; Table 2).
Transfection with another Tmem16a -siRNA-2 had
functional consequences similar to those with Tmem16a -
siRNA. Thus, Tmem16a -siRNA-2 transfection significantly
(P =0.008) suppressed contractile responses to 30 μM NA—
3.82±0.45, 3.51±0.14, and 1.98±0.36 N/m (n =4)—for
nontransfected arteries, arteries transfected with eGFP-
siRNA, and with Tmem16a-siRNA-2, respectively.
Elevation of the extracellular K+ concentration (20 mM)
potentiated the contractile responses to NA in all three
experimental groups but did not modify the difference
between the responses of the groups (Fig. 6). Thus, isolated
arteries transfected with Tmem16a -siRNA were still less
sensitive to NAwith a reduced maximal contractile response
to NA in comparison with both nontransfected arteries and
arteries transfected with nonfunctional siRNA (Fig. 6;
Table 2).
The maximal contractile response to AVPwas also reduced
in isolated arteries transfected with Tmem16a -siRNA in




























































Fig. 2 Downregulation of Tmem16a expression by in vivo transfection
of mesenteric small arteries with siRNA directed against Tmem16a
(Tmem16a-siRNA). a Relative level of Tmem16a mRNA expression in
arteries transfected with Tmem16a -siRNA, with mutated form of
Tmem16a-siRNA (mutated siRNA) or siRNA directed against eGFP
(eGFP-siRNA). Tmem16a expression was normalized to two
housekeeping genes, GAPDH and TFRC, and was set to 100 % in
nontransfected arteries isolated from the same rat. n =6, ***P <0.01. b
TMEM16A protein expression (quantified by immunofluorescence) was
significantly reduced in SMCs isolated from arteries transfected with
Tmem16a-siRNA in comparison with SMCs transfected with nonrelated
siRNA. Results averaged from 43 to 69 cells isolated from eGFP-siRNA
and Tmem16a-siRNA-transfected arteries (paired) from three rats; ***P
<0.01. c Representative examples for the experiments shown in b . SMCs
were isolated from mesenteric small arteries segments transfected with
eGFP-siRNA (left panel) and Tmem16a-siRNA (right panel) and stained
with TMEM16A antibody. Fluorescence of cells incubated with only
secondary antibody and without primary antibody was set as a
background. The same settings were used for all recordings.Bars indicate
20 μm
1398 Pflugers Arch - Eur J Physiol (2014) 466:1391–1409
transfected with nonfunctional siRNA: although no
significant difference in sensitivity to AVP between arteries
transfected with Tmem16a -siRNA and nontransfected arteries
was observed (Fig. 7). Similar to NA-stimulated arteries, the
arteries transfected with mutated nonfunctional siRNA were
more sensitive to AVP than nontransfected and TMEM16A-
downregulated arteries (Fig. 7a; Table 2). The transfection
with eGFP-siRNA did not affect contractile responses to AVP
or agonist sensitivity when compared with nontransfected
arteries (Fig. 7c).
The contractile response to 124 mM K+ in the presence of
1 μM phentolamine was significantly reduced in isolated
arteries transfected with Tmem16a -siRNA in comparison
with nontransfected arteries and arteries transfected with
mutated Tmem16a -siRNA (Table 2). The response to K+
depolarization was also significantly reduced (P =0.008) in
arteries transfected with Tmem16a-siRNA-2 (1.21±0.23 N/
m, n =4) in comparison with nontransfected arteries (2.47±
0.40 N/m) and arteries transfected with eGFP-siRNA (2.48±
0.28 N/m).
In contrast, the contractile responses to 10 mM caffeine, to
evoke release of Ca2+ from caffeine-sensitive intracellular
stores, were not different between the groups. Both
Tmem16a -siRNA (Table 2) and Tmem16a -siRNA-2 (0.39±
0.08, 0.39±0.07, and 0.36±0.06 N/m for nontransfected,
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Zn2+-sensitive Ca2+-activated Cl- current – eGFP-siRNA
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the niflumic acid-sensitive and the
Zn2+-sensitive Ca2+-activated Cl−
currents in SMCs isolated from
rat mesenteric small arteries
transfected with Tmem16a-
siRNA in vivo. a Representative
recordings from SMCs
transfected with siRNA directed
against eGFP (eGFP-siRNA) or
with Tmem16a-siRNA.
Membrane currents were
recorded by stepping holding
voltage between −60 and +60 mV




incubation with 100 μM niflumic
acid, 300 μM 8Br-cGMP, and
10 μM ZnCl2, as indicated. b
Averaged current–voltage
characteristics for the niflumic
acid (NFA)-sensitive and the
Zn2+-sensitive Ca2+-activated Cl−
currents calculated from the
experiments similar to those
shown in a . c The whole-cell
slope conductances (between −20
and +20 mV) of two currents in b
measured in SMCs transfected
with either siRNA directed
against eGFP (eGFP-siRNA) or
with Tmem16a-siRNA. n =9–13;
**P<0.01
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arteries, respectively; n =4) transfections had no effect on
caffeine-induced contraction. No difference in relaxation to
10 μM acetylcholine was found between the groups,




No difference in the resting membrane potentials of SMCs in
arteries transfected with eGFP-siRNA and TMEM16A-
downregulated arteries was found (Fig. 8). NA stimulation
depolarized the SMCs in both groups; however, the NA-
induced depolarization was significantly reduced in
TMEM16A-downregulated arteries compared with eGFP-
siRNA-transfected arteries (Fig. 8). In contrast, elevation of
extracellular K+ to 60 mM equally depolarized the membrane
potential in TMEM16A-downregulated arteries and eGFP-
siRNA-transfected arteries. Interestingly, while the SMCs in
these arteries produced a similar depolarization to K+, the
TMEM16A-downregulated arteries still had a reduced
contractile response in comparison with eGFP-siRNA-
transfected arteries (Fig. 8). The contractile response to K+-
induced depolarization was completely blocked by 10 μM

































0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5
***
**

























10-7 3•10-7 3•10-610-6 10-5[NA], M: 3•10-5
Fig. 4 Mesenteric small arteries
in vivo respond to exogenous NA
with changes in arterial inner
diameter: matched eGFP-siRNA
and Tmem16a-siRNA-
transfected arteries from the same
rat were compared. a Averaged
inner diameters of arteries
transfected with eGFP-siRNA
and Tmem16a-siRNA and their
changes in response to NA. n =7,
*P<0.05. Representative curves
showing the inner diameter
changes in response to NA of
eGFP-siRNA-transfected artery
(b) and Tmem16a-siRNA-
transfected artery in vivo (c). d
The distribution of vasomotion
amplitudes over oscillation
frequencies 0–0.5 Hz for eGFP-
siRNA-transfected arteries (n =7)
and Tmem16a-siRNA-
transfected arteries in vivo (two
out of seven arteries did not
oscillate and were therefore not
included in the analysis; n =5).
*P<0.05
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TMEM16A downregulation does not affect the expression
of α1-adrenergic receptors
The mRNA levels of different isoforms of α1-adrenergic
receptors expressed in the arterial wall of rat mesenteric small
arteries were not affected by Tmem16a-siRNA transfection
and were not significantly different from those in arteries
transfected with eGFP-siRNA (Fig. 9a). The localization of
α1-adrenergic receptors with BODIPY-prazosin staining
(Fig. 9b, c) did not reveal any significant difference in the
intensity of staining between nontransfected arteries and
arteries transfected with eGFP-siRNA and Tmem16a-siRNA.
Nonselective cationic current is unaffected by TMEM16A
downregulation
Intracellular injection of the G-protein activator GTPγS in
freshly isolated SMCs uncouples the activation of G-
proteins from agonist receptor stimulation and induces a
nonselective cationic membrane current (INSC). The INSC
reached a peak 3–7 min after breaking the patch membrane
and the SMC dialyzed with GTPγS in the whole-cell voltage-
clamp configuration (Fig. 10a). This INSC was sensitive to
nonselective inhibition with micromolar application of GdCl3.
There was no significant difference between current–voltage
dependencies of GTPγS-evoked INSC in SMCs isolated from
nontransfected arteries and arteries transfected with either
eGFP-siRNA or Tmem16a-siRNA (Fig. 10b).
NA-induced [Ca2]i
+ increase is reduced
in TMEM16A-downregulated arteries
TMEM16A-downregulated arteries had suppressed [Ca2+]i
changes in response to NA stimulation in comparison with
eGFP-siRNA-transfected arteries (Fig. 11a). The slopes of the
relation between NA-induced contraction and [Ca2+]i increase
were not different between the groups indicating that Ca2+
sensitivity was not affected (Fig. 11b). In contrast, the increase
of [Ca2+]i following release of Ca
2+ from the sarcoplasmic
reticulumwith 10mM caffeine was similar in all experimental
groups (Fig. 11c).
The [Ca2+]i increase in response to elevated extracellular
K+ was significantly reduced in TMEM16A-downregulated
arteries in comparison with eGFP-siRNA-transfected arteries
(Fig. 11c). The mRNA levels for the vascular L-type calcium
channel (cacna1c , CaV1.2) in TMEM16A-downregulated
arteries were reduced to 46 % of those in nontransfected
arteries (Fig. 11d). No significant changes in cacna1c
expression were detected in eGFP-siRNA-transfected arteries.
Vasomotion in vitro is suppressed
in TMEM16A-downregulated arteries
Arteries stimulated with NA to develop about 50 % of their
maximal tone produce vasomotion (Fig. 12). A single
TMEM16A-downregulated artery (out of seven) failed to
develop oscillations. The amplitude of vasomotion in the six
Table 2 Functional characteristics of arteries in isometric experiments.
In one group of experiments, we compared three different groups of
arteries from the same rats: Tmem16a-siRNA-transfected arteries, arteries
transfected with mutated siRNA, and nontransfected arteries. In other
experiments, only eGFP-transfected arteries and nontransfected arteries
from the same rats were compared
Rats transfected with Tmem16a-siRNA and mutated siRNA (n =7) Rats transfected with eGFP-siRNA (n=3)
Nontransfected Tmem16a-siRNA Mutated siRNA Nontransfected eGFP-siRNA
ID (μm) 297±5 305±10 295±11 303±11 297±7
−logEC50 NA 5.68±0.07 5.27±0.06***,### 6.024±0.04** 5.87±0.08 5.82±0.14
−logEC50 AVP 4.99±0.10 4.93±0.09# 5.20±0.07* 5.12±0.05 5.07±0.10
−logEC50 NA+20 mM K+ 5.91±0.06 5.72±0.11*,### 6.32±0.08**
Max NA, N/m 5.88±0.40 2.03±0.50***,## 4.72±0.48 4.81±0.70 4.82±0.97
NA+20 mM K+, N/m 5.70±0.40 2.20±0.45***,# 4.00±0.46
Max AVP, N/m 5.16±0.25 3.36±0.44*,# 5.73±0.55 4.86±0.61 4.99±0.79
Max K+, N/m 5.40±0.42 2.36±0.44**,# 4.20±0.55
Caffeine, N/m 0.70±0.10 0.60±0.06 0.76±0.11
Relaxation to ACh, % 68.01±5.41 65.09±6.17 63.18±5.41 62.11±5.12 65.75±5.21
ID inner diameter, NA noradrenaline, AVP arginine vasopressin, ACh acetylcholine
*P<0.05, **P <0.01, ***P<0.001 vs. nontransfected arteries; #P<0.05, ##P<0.01, ###P<0.001 vs. arteries transfected with mutated, nonfunctional
siRNA
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TMEM16A-downregulated arteries displaying oscillations
was significantly reduced in comparison with nontransfected
arteries, arteries transfected with mutated siRNA, and siRNA
directed against eGFP (Fig. 12). The transfection procedure
itself did not apparently alter vasomotion, since no significant
difference between vasomotion amplitude and frequency was
found in the three control groups of arteries.
Discussion
We find in this study that the expression of TMEM16A is
necessary for the two ICl(Ca) present in vascular SMC.
Moreover, we have found that TMEM16A is an important
modulator of agonist-induced contraction and vasomotion in
rat mesenteric small arteries in vivo and in vitro. Knockdown
of TMEM16Awith siRNA reduces arterial contraction in two
potential ways: via reduced depolarization— as might be
expected for reduction of a vascular Cl− channel—and,
surprisingly, via reduction of voltage-gated Ca2+ channel
expression in the SMC.
TMEM16A as the SMC CaCC
We have previously demonstrated that vascular SMCs have
two Ca2+-activated Cl− conductances [26]: the “classical”
I Cl(Ca) and the cGMP-dependent I Cl(Ca) with distinct
pharmacological and biophysical properties [25, 27, 38, 39].
Downregulation of TMEM16A (confirmed at both mRNA






















































Fig. 5 Downregulation of
TMEM16A suppressed NA-
induced contractile response of
isolated rat mesenteric arteries
in vitro. a Representative trace for
NA concentration–response
experiment. b Concentration–
response to NA of TMEM16A-
downregulated arteries, arteries
transfected with mutated siRNA,
and nontransfected arteries
(n =7). c NA concentration–
contraction relations of eGFP-
siRNA-transfected and
nontransfected arteries in vitro
(n =3). *P <0.05, **P<0.01
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from SMCs: consistent with previous data where the niflumic
acid-sensitive ICl(Ca) was significantly reduced by ex vivo
TMEM16A downregulation in SMCs from pulmonary [24]
and cerebral arteries [4, 44, 46]. These findings taken together
with the predominant near membrane localization of
TMEM16A seen here and the previous suggestions of
TMEM16A as CaCC [5, 47] provide strong evidence that
TMEM16A constitutes the “classical” ICl(Ca) in SMCs of
mesenteric small arteries.
Unexpectedly, downregulation of TMEM16A also led to
disappearance of the cGMP-dependent ICl(Ca). Importantly,
this was accompanied by downregulation in bestrophin-1,
bestrophin-2, and bestrophin3 mRNA, indicating that
bestrophin mRNA regulation is influenced by TMEM16A
expression. We have previously seen that specific
downregulation of bestrophin-3 also downregulates
bestrophin-1 and bestrophin-2 in SMCs [27], making it
difficult to distinguish between whether TMEM16A directly
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Fig. 6 NA-induced contractile response in the presence of 20 mM K+
was suppressed in TMEM16A-downregulated isolated rat mesenteric
arteries in comparison with the arteries transfected with nonfunctional
siRNA and with nontransfected arteries (n=7). *P <0.05, **P<0.01





















































Fig. 7 Downregulation of
TMEM16A reduced AVP-
induced contractile responses of
isolated rat mesenteric small
arteries in vitro. a Representative
trace of a concentration–response
curve for AVP. b Concentration–
response relations for AVP of
TMEM16A-downregulated




response relations for AVP of
eGFP-siRNA-transfected and
nontransfected arteries (n=3)
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controls the expression of all three bestrophins or TMEM16A
regulates one of them, which secondarily leads to
downregulation of the others.
Based on these findings, we suggest two possible models
for interaction between TMEM16A and bestrophins. One
possibility is that one bestrophin (or their combination) forms
the channel responsible for the cGMP-dependent ICl(Ca) and
that TMEM16A through regulation of bestrophin expression
is important for this current. Another possibility is that the
TMEM16A protein alone forms the channel pore for both
Ca2+-activated Cl− conductances, while accessory subunits
(e.g. , bestrophins) impart the biophysical and
pharmacological characteristics of cGMP-dependent ICl(Ca)
conducted by TMEM16A. Bestrophins have previously been
suggested to interact with TMEM16A [1] similar to the
functional and molecular interaction between the cystic
fibrosis transmembrane regulator (CFTR) and TMEM16A
[33]. Future studies will determine the nature of these
interactions.
A potentially important factor contributing to the
variability of a CaCC protein's physical properties is the
expression of different splice variants. We found two splice
variants of TMEM16A in the blood vessels: rat aorta and
mesenteric small arteries express the splice variant “bc” and
“cd.”We were unable to find products containing segment “a,
” while all products contained segment “c,” which is
important for voltage sensitivity [11]. Although the functional
significance of segment “d” is unknown, segment “b” has
been suggested to modulate the Ca2+ sensitivity of the
TMEM16A-associated CaCC [11].
TMEM16A and vascular function
In contrast to our expectations, the mutated (four mismatching
nucleotides) Tmem16a -siRNA significantly potentiated
agonist-induced contraction. The cause of this effect is not
clear: no changes in TMEM16A expression or Cl− currents
were seen after transfection with mutated Tmem16a-siRNA.
Rat mesenteric arteries typically display an increased
sensitivity to agonist(s) and increased maximal response if
the endothelium has been removed [10] or is poorly
functioning; however, we did not find any difference in the
endothelium-derived relaxation elicited by acetylcholine
between the artery groups. While this effect may not be
attributable to an endothelial defect, it is nevertheless an off-
target effect of the mutated siRNA since transfection with
nonrelated eGFP-siRNA was without effect on arterial
contractility.
We found decreased contractile responses to NA and AVP
in the isolated arteries downregulated for TMEM16A. To
elucidate the mechanism for this, we made an in-depth
investigation of the possible factors involved in the reduced
response to NA. Our findings that the NA-induced
depolarization and increase of [Ca2+]i were reduced are
consistent with CaCCs being important for membrane
depolarization and force development [7, 18, 19, 21, 34–36,
41] and the observation that CaCCs can be activated by G-
protein-coupled receptor stimulation [9, 19, 34, 45]. Our
findings are also consistent with a recent report of
TMEM16A in the cerebral vascular bed, where the pressure-
induced depolarization and development of myogenic tone
were reduced when TMEM16A was knocked down ex vivo
[4]. Furthermore, since the increase of [Ca2+]i and force
development to caffeine were identical in the two groups, it
seems unlikely that Ca2+ release and/or alterations in the
contractile proteins are contributing to the reduced agonist-
induced contraction.
However, full substitution of Cl− with aspartate and
dissipation of the elevated intracellular Cl− inhibits all ICl(Ca)
but is without substantial effect on the sensitivity or maximal
contraction to NA [2, 31]. Also downregulation of bestrophin,
which inhibits the cGMP-dependent ICl(Ca), does not affect the
response to NA [3]. Finally, the few studies that have tested
the effect on the membrane potential of the Cl− gradient in
NA-activated arteries have detected only a minimal effect [2,
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Fig. 8 TMEM16A-downregulated arteries can depolarize to the same
extent as eGFP-siRNA-transfected arteries but they have reduced
contractility. Membrane depolarization to NA and tone production in
Tmem16a-siRNA arteries was lower in comparison with eGFP-siRNA-
transfected arteries. Resting membrane potential and depolarization to
60mMK+were unchanged, but force production to elevated extracellular
K+ is also lower in Tmem16a-siRNA arteries compared to eGFP-siRNA
arteries (n =6–7). *P <0.05, **P<0.01
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importance for NA-induced depolarization and force
development were affected. To evaluate an effect on α1-
adrenoceptor expression, we measured α1-receptor mRNA
and fluorescent prazosin binding but found neither to be
affected by downregulation of TMEM16A.We also measured
stimulated cation unspecific current which participates in NA-
induced depolarization, but again found no difference in
arteries downregulated for TMEM16A.
An indication that other pathways may be affected came
from the highly surprising finding that TMEM16A
downregulation also reduces force development to high
extracellular K+. To provide mechanistic insight to this, we
measured membrane potential and [Ca2+]i with high
extracellular K+. While the membrane potential was similar,
[Ca2+]i was lower in the arteries where TMEM16A was
downregulated. The latter finding supports and provides
an explanation for the reduced force development. These
findings could be explained by reduction of L-type Ca2+
channel expression and/or function in the SMCs: to test this
possibility, we measured mRNA expression of the pore-
forming subunit of the L-type voltage-gated Ca2+ channel
and found a significant reduction. The mechanism
responsible for this effect of siRNA directed against
TMEM16A is as yet unclear, but this finding suggests a
complicated functional role for TMEM16A in vascular
tissues. It seems possible that TMEM16A acts as a
multifunctional protein, similar to CFTR, being a CaCC



















































Fig. 9 Downregulation of TMEM16A does not affect the expression of
α1-adrenergic receptors. a Relative mRNA level of α1a, α1b, and α1d
isoforms of adrenergic receptors in arteries transfected with either
Tmem16a -siRNA or siRNA directed against eGFP (eGFP-siRNA).
Tmem16a expression was set to 100 % in nontransfected arteries isolated
from the same rat. n =4. No significant difference between the groups was
found. b The average intensity of BODIPY-prazosin staining
(representative images in c) in the SMCs of the outer layer of the media
(SMC-OL) and the inner layer (SMC-IL) normalized to the intensity
observed in the nontransfected artery (set to 100 %). No significant
difference between nontransfected arteries and arteries transfected with
either Tmem16a-siRNA or eGFP-siRNA was found. c Representative
BODIPY-prazosin staining of Tmem16a-siRNA-transfected arteries (i),
eGFP-siRNA-transfected arteries (ii), and nontransfected arteries (iii) for
BODIPY-prazosin staining and corresponding differential interference
contrast image for the same artery. Scale bar represents 50 μm in all
images
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ion channels, such as the L-type Ca2+ channels [30]. The
extent to which TMEM16A modulates agonist-induced
contraction directly by providing depolarizing current and
indirectly as a modulator of Ca2+ channels is unclear. We
suggest, however, that both these mechanisms may play a
role. Interestingly, bestrophin-1 has previously been shown
to change the properties of voltage-gated Ca2+ channels
[42, 48] and could therefore be suggested as a link between
Ca2+ channels and TMEM16A although our previous study
where we downregulated bestrophins in the vascular wall
does not support this possibility as there was no effect on
arterial contractility [3].
TMEM16A is important for the generation of vasomotion
We have previously suggested that the cGMP-dependent
ICl(Ca) is important for synchronization of vascular SMCs
during rat mesenteric artery vasomotion [37]. We have
recently supported this hypothesis by demonstrating that
downregulation of the bestrophins and consequently
cGMP-dependent ICl(Ca) [27] suppresses the amplitude of
vasomotion without affecting the frequency [3]. The
current study provides additional evidence for this by
showing that suppression of the cGMP-dependent ICl(Ca)
by downregulation of TMEM16A also reduced vasomotion
amplitude. We have shown that vasomotion, which is well
characterized in vitro, is also present in rat mesenteric artery
in vivo. Importantly, the prevalence and coordination of
vasomotion in vivo were significantly reduced by TMEM16A
downregulation. Although the membrane of TMEM16A
downregulated arteries depolarized less to NA (to~−45 mV)
compared to the control (~−35 mV), which in itself could
influence the ability of the membrane potential to oscillate,
we have previously shown that rat mesenteric small arteries












































Fig. 10 Downregulation of
TMEM16A has no effect on
nonselective cation current
(INSC). INSC was evoked by
dialyses of isolated SMCs with
400 μM GTPγS from the patch
pipette. SMCs were held
at −50 mVand the GTPγS-
evoked INSC current reached a
peak 3 to 7 min after
breakthrough to the whole-cell
configuration (indicated by an
arrow in a). This INSC was
inhibited by 10 μM GdCl3. a
Representative current trace at
holding potential −50 mV
recorded on SMC isolated from






through the patch membrane and
the peak INSC recorded in SMCs
isolated from nontransfected
arteries (n =6), arteries transfected
with eGFP-siRNA (n =6), and
arteries transfected with
Tmem16a-siRNA (n=8)
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Fig. 11 Downregulation of TMEM16A suppresses intracellular Ca2+
([Ca2+]i) rises in response to NA and K
+, partly as a consequence of
reduced expression of vascular L-type calcium channel (CaV1.2). a
Changes in [Ca2+]i in response to increasing concentration of NA.
[Ca2+]i signaling is normalized to averaged maximal [Ca
2+]i level
obtained in arteries transfected with eGFP-siRNA after 10 μM NA
stimulation (n =6). *P <0.05, **P <0.01, ***P <0.001. b Ca2+
sensitivity expressed as a relation between wall tension and normalized
[Ca2+]i, as shown in a (n =6). c Changes in [Ca
2+]i, in response to
60 mM K+-induced depolarization and 10 mM caffeine stimulation.
[Ca2+]i signaling is normalized to averaged maximal [Ca
2+]i level in
arteries transfected with eGFP-siRNA after 10 μM NA stimulation (n=
6). *P <0.05. d Expression of CaV1.2 in TMEM16A-downregulated
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Fig. 12 Downregulation of
TMEM16A reduced the
amplitude but not the frequency
of NA-induced vasomotion in
isolated rat mesenteric small
arteries in vitro. a Representative
recordings of NA-induced
vasomotion in nontransfected and
TMEM16A-downregulated
arteries. b The distribution of
vasomotion amplitudes over
oscillation frequencies 0–0.5 Hz.
***P<0.001 for arteries
transfected with mutated siRNA
(n =6) vs. TMEM16A-
downregulated arteries (n =6).
++P<0.01 for nontransfected
arteries (n =9) vs. TMEM16A-
downregulated arteries. ‡‡P<0.01
for eGFP-siRNA transfected
arteries (n =3) vs. TMEM16A-
downregulated arteries
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Conclusion
The present study clearly demonstrates the expression and
functional significance of TMEM16A in SMCs in rat
mesenteric small arteries. Expression of TMEM16A was
necessary for two biophysically and pharmacologically
different Ca2+-activated Cl− currents in vascular SMCs.
TMEM16A was found to be important for vasomotion: this
effect is likely at least in part due to the concurrent loss of the
cGMP component of Ca2+-activated Cl− conductance in
SMCs. Interestingly, downregulation of TMEM16A was
followed by a reduction of agonist-induced contraction, which
is associated with a reduction of [Ca2+]i and may only in part
be explained by reduced depolarization. At the same
depolarized potential (with high K+), [Ca2+]i was also reduced
in TMEM16A-downregulated arteries, which intriguingly
might be explained by altered L-type Ca2+ channel expression
as we observe reducedmRNA for this channel. Further studies
are necessary to clarify how and to what extent TMEM16A
expression affects other transmembrane proteins and/or ion
channels.
Acknowledgments We thank Jane Holbæk Rønn, Jørgen Andresen,
Viola Smed Mose Larsen, and Sukhan Kim for excellent technical
assistance. The study was supported by the Danish Research Council,
the Lundbeck Foundation, and the Novo Nordisk Foundation.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
Reference
1. Barro-Soria R, Aldehni F, Almaca J, Witzgall R, Schreiber R,
Kunzelmann K (2010) ER-localized bestrophin 1 activates Ca2+-
dependent ion channels TMEM16A and SK4 possibly by acting as
a counterion channel. Pflugers Arch 459:485–497
2. Boedtkjer DM, Matchkov VV, Boedtkjer E, Nilsson H, Aalkjaer C
(2008) Vasomotion has chloride-dependency in rat mesenteric small
arteries. Pflugers Arch 457:389–404
3. Broegger T, Jacobsen JC, Secher DV, Boedtkjer DM, Kold-Petersen
H, Pedersen FS, Aalkjaer C, Matchkov VV (2011) Bestrophin is
important for the rhythmic but not the tonic contraction in rat
mesenteric small arteries. Cardiovasc Res 91:685–693
4. Bulley S, Neeb ZP, Burris SK, Bannister JP, Thomas-Gatewood CM,
Jangsangthong W, Jaggar JH (2012) TMEM16A channels contribute
to the myogenic response in cerebral arteries. Circ Res 111:1027–1036
5. Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E,
Pfeffer U, Ravazzolo R, Zegarra-Moran O, Galietta LJ (2008)
TMEM16A, a membrane protein associated with calcium-
dependent chloride channel activity. Science 322:590–594
6. Chipperfield AR, Harper AA (2000) Chloride in smooth muscle.
Prog Biophys Mol Biol 74:175–221
7. Criddle DN, de Moura RS, Greenwood IA, Large WA (1996) Effect
of niflumic acid on noradrenaline-induced contractions of the rat
aorta. Br J Pharmacol 118:1065–1071
8. Davis AJ, Forrest AS, Jepps TA, Valencik ML, Wiwchar M, Singer
CA, SonesWR,Greenwood IA, Leblanc N (2010) Expression profile
and protein translation of TMEM16A in murine smooth muscle. Am
J Physiol 299:C948–C959
9. Elble RC, Ji G, Nehrke K, DeBiasio J, Kingsley PD, Kotlikoff MI,
Pauli BU (2002) Molecular and functional characterization of a
murine calcium-activated chloride channel expressed in smooth
muscle. J Biol Chem 277:18586–18591
10. Falloon BJ, Stephens N, Tulip JR, Heagerty AM (1995) Comparison
of small artery sensitivity and morphology in pressurized and wire-
mounted preparations. Am J Physiol 268:H670–H678
11. Ferrera L, Caputo A, Ubby I, Bussani E, Zegarra-Moran O,
Ravazzolo R, Pagani F, Galietta LJ (2009) Regulation of
TMEM16A chloride channel properties by alternative splicing. J
Biol Chem 284:33360–33368
12. Ferrera L, Scudieri P, Sondo E, Caputo A, Caci E, Zegarra-Moran O,
Ravazzolo R, Galietta LJ (2011) A minimal isoform of the
TMEM16A protein associated with chloride channel activity.
Biochim Biophys Acta 1808:2214–2223
13. Galietta LJ (2009) The TMEM16 protein family: a new class of
chloride channels? Biophys J 97:3047–3053
14. Greenwood IA, Leblanc N (2007) Overlapping pharmacology of
Ca2+-activated Cl- and K+ channels. Trends Pharmacol Sci 28:1–5
15. Hartzell C, Putzier I, Arreola J (2005) Calcium-activated chloride
channels. Annu Rev Physiol 67:719–758
16. Hartzell HC (2008) Physiology CaCl-ing channels get the last laugh.
Science 322:534–535
17. Huang F, Rock JR, Harfe BD, Cheng T, Huang X, Jan YN, Jan LY
(2009) Studies on expression and function of the TMEM16A
calcium-activated chloride channel. Proc Natl Acad Sci U S A 106:
21413–21418
18. Janssen LJ, Sims SM (1992) Acetylcholine activates non-selective
cation and chloride conductances in canine and guinea-pig tracheal
myocytes. J Physiol 453:197–218
19. Kirkup AJ, Edwards G, Green ME, Miller M, Walker SD, Weston
AH (1996) Modulation of membrane currents and mechanical
activity by niflumic acid in rat vascular smooth muscle. Eur J
Pharmacol 317:165–174
20. Kunzelmann K, Tian Y, Martins JR, Faria D, Kongsuphol P,
Ousingsawat J, Thevenod F, Roussa E, Rock J, Schreiber R (2011)
Anoctamins. Pflugers Arch 462:195–208
21. Lamb FS, Kooy NW, Lewis SJ (2000) Role of Cl(−) channels in
alpha-adrenoceptor-mediated vasoconstriction in the anesthetized rat.
Eur J Pharmacol 401:403–412
22. Large WA, Wang Q (1996) Characteristics and physiological role of
the Ca2+-activated Cl− conductance in smooth muscle. Am J Physiol
271:C435–C454
23. Leblanc N, Ledoux J, Saleh S, Sanguinetti A, Angermann J,
O'Driscoll K, Britton F, Perrino BA, Greenwood IA (2005)
Regulation of calcium-activated chloride channels in smooth muscle
cells: a complex picture is emerging. Can J Physiol Pharmacol 83:
541–556
24. Manoury B, Tamuleviciute A, Tammaro P (2010) TMEM16A/
anoctamin 1 protein mediates calcium-activated chloride currents in
pulmonary arterial smooth muscle cells. J Physiol 588:2305–2314
25. Matchkov VV, Aalkjaer C, Nilsson H (2004) A cyclic GMP-
dependent calcium-activated chloride current in smooth-muscle cells
from rat mesenteric resistance arteries. J Gen Physiol 123:121–134
26. Matchkov VV, Aalkjaer C, Nilsson H (2005) Distribution of cGMP-
dependent and cGMP-independent Ca2+-activated Cl− conductances
in smooth muscle cells from different vascular beds and colon.
Pflugers Arch 451:371–379
27. Matchkov VV, Larsen P, Bouzinova EV, Rojek A, Boedtkjer DM,
Golubinskaya V, Pedersen FS, Aalkjaer C, Nilsson H (2008)
Bestrophin-3 (vitelliform macular dystrophy 2-like 3 protein) is
1408 Pflugers Arch - Eur J Physiol (2014) 466:1391–1409
essential for the cGMP-dependent calcium-activated chloride
conductance in vascular smooth muscle cells. Circ Res 103:864–872
28. Matchkov VV, Moeller-Nielsen N, Secher DV, Nourian Z, Bodtkjer
DM, Aalkjaer C (2012) The alpha2 isoform of the Na,K-pump is
important for intercellular communication, agonist-induced
contraction and EDHF-like response in rat mesenteric arteries. Am
J Physiol 303:H36–H46
29. Matchkov VV, Rahman A, Bakker LM, Griffith TM, Nilsson H,
Aalkjaer C (2006) Analysis of effects of connexin-mimetic peptides
in rat mesenteric small arteries. Am J Physiol 291:H357–H367
30. Mehta A (2005) CFTR: more than just a chloride channel. Pediatr
Pulmonol 39:292–298
31. Nilsson H, Videbaek LM, Toma C, Mulvany MJ (1998) Role of
intracellular calcium for noradrenaline-induced depolarization in rat
mesenteric small arteries. J Vasc Res 35:36–44
32. Okamoto H, Unno T, Arima D, Suzuki M, Yan HD, Matsuyama H,
Nishimura M, Komori S (2004) Phospholipase C involvement in
activation of the muscarinic receptor-operated cationic current in
guinea pig ileal smooth muscle cells. J Pharmacol Sci 95:203–213
33. Ousingsawat J, Kongsuphol P, Schreiber R, Kunzelmann K (2011)
CFTR and TMEM16A are separate but functionally related Cl
channels. Cell Physiol Biochem 28:715–724
34. Pacaud P, Loirand G, Baron A, Mironneau C, Mironneau J (1991)
Ca2+ channel activation and membrane depolarization mediated by
Cl− channels in response to noradrenaline in vascular myocytes. Br J
Pharmacol 104:1000–1006
35. Pacaud P, Loirand G, Gregoire G, Mironneau C, Mironneau J (1992)
Calcium-dependence of the calcium-activated chloride current in
smooth muscle cells of rat portal vein. Pflugers Arch 421:125–130
36. Parai K, Tabrizchi R (2002) A comparative study of the effects of Cl−
channel blockers on mesenteric vascular conductance in
anaesthetized rat. Eur J Pharmacol 448:59–66
37. Peng H, Matchkov V, Ivarsen A, Aalkjaer C, Nilsson H (2001)
Hypothesis for the initiation of vasomotion. Circ Res 88:810–815
38. Piper AS, Large WA (2004) Direct effect of Ca2+/calmodulin on
cGMP-activated Ca2+-dependent Cl− channels in rat mesenteric
artery myocytes. J Physiol 559:449–457
39. Piper AS, Large WA (2004) Single cGMP-activated Ca2+-dependent
Cl− channels in rat mesenteric artery smooth muscle cells. J Physiol
555:397–408
40. Pusch M (2004) Ca2+-activated chloride channels go molecular. J
Gen Physiol 123:323–325
41. Remillard CV, Lupien MA, Crepeau V, Leblanc N (2000) Role of
Ca2+- and swelling-activated Cl− channels in alpha1-adrenoceptor-
mediated tone in pressurized rabbit mesenteric arterioles. Cardiovasc
Res 46:557–568
42. Rosenthal R, Bakall B, Kinnick T, Peachey N, Wimmers S,
Wadelius C, Marmorstein A, Strauss O (2006) Expression of
bestrophin-1, the product of the VMD2 gene, modulates voltage-
dependent Ca2+ channels in retinal pigment epithelial cells. FASEB
J 20:178–180
43. Schroeder BC, Cheng T, Jan YN, Jan LY (2008) Expression cloning
of TMEM16A as a calcium-activated chloride channel subunit. Cell
134:1019–1029
44. Thomas-Gatewood C, Neeb ZP, Bulley S, Adebiyi A, Bannister JP,
Leo MD, Jaggar JH (2011) TMEM16A channels generate Ca(2)-
activated Cl currents in cerebral artery smooth muscle cells. Am J
Physiol 301:H1819–H1827
45. Van Renterghem C, Lazdunski M (1993) Endothelin and vasopressin
activate low conductance chloride channels in aortic smooth muscle
cells. Pflugers Arch 425:156–163
46. Wang M, Yang H, Zheng LY, Zhang Z, Tang YB, Wang GL, Du
YH, Lv XF, Liu J, Zhou JG, Guan YY (2012) Downregulation of
TMEM16A calcium-activated chloride channel contributes to
cerebrovascular remodeling during hypertension through
promoting basilar smooth muscle cell proliferation. Circulation
125:697–707
47. YangYD, ChoH, Koo JY, TakMH,ChoY, ShimWS, Park SP, Lee J,
Lee B, Kim BM, Raouf R, Shin YK, Oh U (2008) TMEM16A
confers receptor-activated calcium-dependent chloride conductance.
Nature 455:1210–1215
48. Yu K, Xiao Q, Cui G, Lee A, Hartzell HC (2008) The best disease-
linked Cl−channel hBest1 regulates Ca V 1 (L-type) Ca2+ channels
via src-homology-binding domains. J Neurosci 28:5660–5670
Pflugers Arch - Eur J Physiol (2014) 466:1391–1409 1409
